Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas.

Specific antisera against three mammalian β-galactoside-specific lectins of apparent molecular weights 14.5 kDa, 18 kDa and 29 kDa have been used to localize these lectins in normal breast, and in benign and malignant mammary lesions. In normal breast tissue discrete localization of two lectins (Ms 14.5 kDa and 18 kDa) was demonstrated in fibroblasts, smooth muscle cells, myoepithelial cells and capillary endothelium. Extracellular localization of one lectin (M 14.5 kDa) in collagen was apparent. The third lectin (M 29 kDa) labelled preferentially luminal cells and their secretory product. Two benign tumours (an analyzed fibroadenoma and a papilloma) revealed strong staining with two lectins (Ms 18 kDa and 29 kDa). Of the 24 mammary carcinomas examined, the lectin (M 14.5 kDa) was expressed by only occasional tumour cells, the lectin (M 18 kDa) occurred in many tumour cells and the lectin (M 29 kDa) labelled tumour cells in nearly all cases. The expression of these β-galactoside-specific endogenous lectins therefore appears to be regulated differently in normal breast compared with mammary tumours. [ABSTRACT FROM AUTHOR]